Reconsidering Assumptions of Adolescent and Young Adult Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Dynamics.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
30 07 2021
Historique:
received: 04 08 2020
accepted: 03 09 2020
pubmed: 8 9 2020
medline: 5 8 2021
entrez: 7 9 2020
Statut: ppublish

Résumé

Evidence regarding the important role of adolescents and young adults (AYA) in accelerating and sustaining coronavirus disease 2019 (COVID-19) outbreaks is growing. Furthermore, data suggest that 2 known factors that contribute to high severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmissibility-presymptomatic transmission and asymptomatic case presentations-may be amplified in AYA. However, AYA have not been prioritized as a key population in the public health response to the COVID-19 pandemic. Policy decisions that limit public health attention to AYA and are driven by the assumption of insignificant forward transmission from AYA pose a risk of inadvertent reinvigoration of local transmission dynamics. In this viewpoint, we highlight evidence regarding the increased potential of AYA to transmit SARS-CoV-2 that, to date, has received little attention, discuss adolescent and young adult-specific considerations for future COVID-19 control measures, and provide applied programmatic suggestions.

Identifiants

pubmed: 32894747
pii: 5902518
doi: 10.1093/cid/ciaa1348
pmc: PMC7499536
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S146-S163

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA011041
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH067127
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Pediatrics. 2015 Dec;136(6):e1587-99
pubmed: 26620067
Euro Surveill. 2020 May;25(21):
pubmed: 32489179
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Nat Commun. 2020 Nov 12;11(1):5749
pubmed: 33184277
J Pediatr. 2020 Aug;223:183-185
pubmed: 32445649
J Infect. 2020 Jun;80(6):e1-e13
pubmed: 32283156
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
MMWR Morb Mortal Wkly Rep. 2020 Mar 06;69(9):245-246
pubmed: 32134909
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
Clin Infect Dis. 2020 Nov 19;71(16):2298
pubmed: 32297915
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):751-758
pubmed: 32555138
Trends Neurosci. 2020 Jun;43(6):355-357
pubmed: 32359765
Lancet Child Adolesc Health. 2020 May;4(5):397-404
pubmed: 32272089
JAMA. 2020 Jun 16;323(23):2427-2429
pubmed: 32432657
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Science. 2020 Aug 28;369(6507):1106-1109
pubmed: 32694200
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Pediatr Infect Dis J. 2020 Aug;39(8):e199-e200
pubmed: 32516281
Science. 2020 Jun 26;368(6498):1481-1486
pubmed: 32350060
Brain Behav Immun. 2020 Jul;87:34-39
pubmed: 32298803
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Arch Dis Child. 2020 Jul;105(7):618-619
pubmed: 32371442
Emerg Infect Dis. 2020 Jun;26(6):1341-1343
pubmed: 32191173
Clin Infect Dis. 2020 Dec 17;71(10):2752-2756
pubmed: 32463076
Dev Neuropsychol. 2019 Aug;44(5):417-428
pubmed: 31288587
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
JAMA Netw Open. 2020 May 1;3(5):e208292
pubmed: 32379329
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Innovation (N Y). 2020 May 21;1(1):100001
pubmed: 33554183
MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):830-835
pubmed: 32614814

Auteurs

Vincent Guilamo-Ramos (V)

Center for Latino Adolescent and Family Health, New York University, New York, New York, USA.
Adolescent AIDS Program, Department of Pediatrics, Children's Hospital at Montefiore Medical Center, Bronx, New York, USA.
Center for Drug Use and HIV Research, New York, New York, USA.
US Presidential Advisory Council on HIV/AIDS, Washington, DC, USA.

Adam Benzekri (A)

Center for Latino Adolescent and Family Health, New York University, New York, New York, USA.

Marco Thimm-Kaiser (M)

Center for Latino Adolescent and Family Health, New York University, New York, New York, USA.
City University of New York, School of Public Health and Health Policy, New York, New York, USA.

Andrew Hidalgo (A)

Center for Latino Adolescent and Family Health, New York University, New York, New York, USA.

David C Perlman (DC)

Center for Drug Use and HIV Research, New York, New York, USA.
Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH